Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4071252 | 1.00 | MCHR1 (0.86) | MCHR1KCNH2 | |
| SCHEMBL4069452 | 1.00 | MCHR1 (0.86) | MCHR1KCNH2 | |
| SCHEMBL4071255 | 1.00 | MCHR1 (0.86) | MCHR1KCNH2 | |
| SCHEMBL4067799 | 0.92 | MCHR1 (1.00) | MCHR1KCNH2 | |
| SCHEMBL4072738 | 0.92 | MCHR1 (1.00) | MCHR1KCNH2 | |
| SCHEMBL4067014 | 0.86 | MCHR1 (0.82) | MCHR1KCNH2 | |
| SCHEMBL4071058 | 0.86 | MCHR1 (0.82) | MCHR1KCNH2 | |
| SCHEMBL13664927 | 0.85 | MCHR1 (0.84) | MCHR1KCNH2 | |
| SCHEMBL4073499 | 0.84 | MCHR1 (0.86) | MCHR1KCNH2 | |
| SCHEMBL4068620 | 0.84 | MCHR1 (0.86) | MCHR1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090247560-A1 | Diaryl ketimine derivative | BANYU PHARMACEUTICAL CO., LTD. | 2009-10-01 | — | — | US | disclosed |
| EP-2072519-A1 | DIARYL KETIMINE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2009-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247560-A1 | Diaryl ketimine derivative | NR0B2, NR2C2, NR3C2 | MCHR1 730/4885KCNH2 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.